Mainz Biomed (MYNZ) News Today $6.68 +1.91 (+40.04%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Mainz Biomed, Quest Diagnostics To Commercialize NextGen Colorectal Cancer Screening Test; Stock UpDecember 20 at 1:01 AM | markets.businessinsider.comMainz Biomed forms agreement with Quest DiagnosticsDecember 20 at 1:01 AM | markets.businessinsider.comMainz Biomed Enters Agreement with Quest Diagnostics to Advance ColoAlert Colorectal Cancer Screening TestDecember 19 at 8:51 AM | quiverquant.comQuest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S.December 19 at 8:51 AM | benzinga.comMainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening TestDecember 19 at 8:01 AM | globenewswire.comMainz Biomed-Aktie erreicht 52-Wochen-Tief bei 4,3 US-DollarDecember 18 at 3:15 PM | de.investing.comMainz BioMed NV: Mainz Biomed Announces Closing of $8.0 Million Follow-On OfferingDecember 17, 2024 | finanznachrichten.deMainz Biomed Secures $8 Million in Follow-On OfferingDecember 17, 2024 | markets.businessinsider.comMainz Biomed N.V. Completes Follow-On Offering Raising Approximately $8 MillionDecember 16, 2024 | quiverquant.comMainz Biomed Announces Closing of $8.0 Million Follow-On OfferingDecember 16, 2024 | globenewswire.comMainz Biomed NV trading halted, volatility trading pauseDecember 16, 2024 | tipranks.comMainz Biomed NV trading resumesDecember 16, 2024 | tipranks.comMainz BioMed NV: Mainz Biomed Announces Pricing of $8.0 Million Follow-On Offering Priced at-the-Market Under Nasdaq RulesDecember 14, 2024 | finanznachrichten.deMainz Biomed Prices $8 Million Follow-On Offering to Boost Diagnostics OperationsDecember 13, 2024 | tipranks.comMainz Biomed prices $8.0M at-the-market offering at $5.85 per unitDecember 13, 2024 | tipranks.comMainz Biomed prices $8M offering of shares and warrantsDecember 13, 2024 | seekingalpha.comMainz Biomed N.V. Announces Pricing of Follow-On Offering to Raise Approximately $8.0 MillionDecember 12, 2024 | quiverquant.comMainz Biomed Announces Pricing of $8.0 Million Follow-On Offering Priced at-the-Market Under Nasdaq RulesDecember 12, 2024 | globenewswire.comMainz Biomed-Aktie erreicht 52-Wochen-Tief bei 6,12 US-DollarDecember 10, 2024 | de.investing.comMainz Biomed stock hits 52-week low at $6.12 amid market challengesDecember 10, 2024 | investing.comMainz Biomed Announces Reverse Stock Split Soon After Collaborating With MedTech Giant Thermo Fisher ScientificDecember 3, 2024 | benzinga.comMainz Biomed Announces Reverse Stock Split Soon After Collaborating With MedTech Giant Thermo Fisher ScientificDecember 3, 2024 | benzinga.comMainz Biomed NV trading halted, news pendingDecember 2, 2024 | tipranks.comMainz BioMed NV: Mainz Biomed Announces Stock SplitDecember 2, 2024 | finanznachrichten.deMainz Biomed-Aktie erreicht 52-Wochen-Tief bei 0,18 US-DollarDecember 2, 2024 | de.investing.comMainz Biomed $MYNZ & Thermo Fisher Partner On Next-Gen Colorectal Cancer Screening ProductNovember 29, 2024 | msn.comMainz Biomed Initiates Reverse Stock Split Amid Nasdaq ChallengeNovember 29, 2024 | tipranks.comMainz Biomed announces 1-for-40 reverse stock splitNovember 29, 2024 | tipranks.comMainz Biomed Announces 1-for-40 Reverse Stock Split to Comply with Nasdaq Listing StandardsNovember 29, 2024 | quiverquant.comMainz Biomed Announces Stock SplitNovember 29, 2024 | globenewswire.comHC Wainwright & Co. Downgrades Mainz Biomed N.V. (MYNZ)November 26, 2024 | msn.comMainz Biomed downgraded to Neutral from Buy at H.C. WainwrightNovember 25, 2024 | tipranks.comMainz Biomed Considers Reverse Stock Split for Nasdaq ComplianceNovember 15, 2024 | markets.businessinsider.comMainz Biomed Partners with Thermo Fisher for Cancer ScreeningNovember 12, 2024 | markets.businessinsider.comMainz Biomed, Thermo Fisher sign collaboration agreementNovember 12, 2024 | markets.businessinsider.comEQS-News: Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate UpdateOctober 22, 2024 | markets.businessinsider.comMainz Biomed restructured operations, implemented cost reductionsOctober 21, 2024 | markets.businessinsider.comMainz Biomed Highlights Growth and Innovations for 2025October 21, 2024 | markets.businessinsider.comMainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate UpdateOctober 21, 2024 | globenewswire.comMainz Biomed Secures Additional $1.5M FundingOctober 10, 2024 | finance.yahoo.comMainz Biomed Reports Increased Demand for Enhanced ColoAlert, Existing Partners to Transition to New VersionOctober 8, 2024 | globenewswire.comMainz Biomed $MYNZ Introduces The Newest Addition To Their TeamOctober 4, 2024 | msn.comMainz Biomed (NASDAQ:MYNZ) Stock, Short Interest ReportOctober 2, 2024 | benzinga.comThe Covid Era Tech Promises To Reinvent Cancer TreatmentOctober 1, 2024 | finance.yahoo.comMainz Biomed plant FDA-Studie für Krebstest im Jahr 2025October 1, 2024 | de.investing.comEQS-News: Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025October 1, 2024 | markets.businessinsider.comMainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025October 1, 2024 | globenewswire.comMainz Biomed-Aktie stürzt auf 52-Wochen-Tief von 0,21 US-DollarSeptember 25, 2024 | de.investing.comClínica Baviera, S.A. (CBAV.MC)September 21, 2024 | finance.yahoo.comPfizer Advances On Its Cancer JourneySeptember 21, 2024 | benzinga.com Get Mainz Biomed News Delivered to You Automatically Sign up to receive the latest news and ratings for MYNZ and its competitors with MarketBeat's FREE daily newsletter. Email Address We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy. Click to get the name and ticker symbol MYNZ Media Mentions By Week MYNZ Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MYNZ News Sentiment▼-0.080.60▲Average Medical News Sentiment MYNZ News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MYNZ Articles This Week▼132▲MYNZ Articles Average Week Get Mainz Biomed News Delivered to You Automatically Sign up to receive the latest news and ratings for MYNZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Precision BioSciences News Lexaria Bioscience News OncoCyte News Actinium Pharmaceuticals News Barinthus Biotherapeutics News CalciMedica News Elevation Oncology News VYNE Therapeutics News Lumos Pharma News Tempest Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MYNZ) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mainz Biomed Please log in to your account or sign up in order to add this asset to your watchlist. Share Mainz Biomed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MYNZ Stock Alerts